Latest News
-
Rs 14/Share Dividend: Stockbroking Co To Consider Bonus Share, Shares Up 126% In 180-Days -
Varyaa Creations IPO Set To Shine: Boasts Robust GMP Of Rs 100 -
BEL, HAL, Cochin, Mazagon Dock: Why Defence Stocks Are Flying High When Middle East Is In Kaboom? -
FII-Backed Penny Stock Issues New Update On Warrants, Shares Gain 111% In 3-Yrs -
Top 5 Bank Savings Accounts With No Hidden Charges; Check Details? -
150% Gains In 12 Months: This Multibagger Telecom Stock Hits 52-Week High; IIFL Finance Recommends BUY! -
Singapore Orders Recall Of Everest Fish Curry Masala Over Pesticide -
China's Sinking Cities: Researchers Warn Of A Looming Threat, Say Half Of Major Cities Are Drowning -
Inox Wind Secures Repeat 210 MW Order From Hero Future Energies -
100 Grams Of 22K Gold Dearer By Rs 5000 In India: Check Yellow Metal Prices After Latest Rise
Rossari Biotech Files For IPO Worth Rs 700 Crore With SEBI
On Wednesday, Rossari Biotech Limited filed its draft papers with capital markets regulator SEBI (Securities and Exchange Board of India) to float a Rs 700 crore initial public offering (IPO). Rossario Biotech is a speciality chemical maker with a focus on home and personal care products.
The IPO will include fresh issuance of shares worth Rs 150 crore and sale of 1.05 crore equity shares by the company's promoters through the offer-for-sale (OFS) route, as per the company's draft prospectus filed with the SEBI.
New agency PTI's market sources have valued the IPO at Rs 700 crore.
The Mumbai-based company may consider a private pre-IPO placement of equity shares aggregating up to Rs 100 crore. If undertaken, the aggregated amount will be reduced from the fresh issue.
The company plans to utilise the net proceeds towards repayment or prepayment of certain indebtedness availed by Rossari Biotech, to fund working capital requirements and for general corporate purposes.
